Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems

Critical Reviews in Biotechnology

Volumn 19, Issue 4, 1999, Pages 317-357

  Patel, Girishchandra B ^a   Sprott, G Dennis ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Adjuvant; Archaeobacteria; Archaeosomes; Ether lipids; Liposomes; Stability

Indexed keywords

ANTIGEN; BILE SALT; BOVINE SERUM ALBUMIN; ETHER DERIVATIVE; ETHER LIPID; FREUND ADJUVANT; GLYCEROLIPID; LIPOSOME; MEMBRANE LIPID; PHOSPHOLIPASE; PHOSPHOLIPID DERIVATIVE; PHYTANIC ACID; SQUALENE DERIVATIVE; UBIDECARENONE; VACCINE;

ARCHAEBACTERIUM; BIOCOMPATIBILITY; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RESEARCH; ENZYME ACTIVITY; HUMAN; HUMORAL IMMUNITY; MACROPHAGE; NONHUMAN; PH; PRIORITY JOURNAL; REVIEW; SERUM; THERMOSTABILITY; TISSUE DISTRIBUTION;

ARCHAEA; BACTERIA (MICROORGANISMS); BOVINAE; EUKARYOTA; METHANOBACTERIA;

EID: 0033426879     PISSN: 07388551     EISSN: None     Source Type: Journal    
DOI: 10.1080/0738-859991229170     Document Type: Review

References (152)

1. Adams, D. H., Joyce, G., Richardson, V. J., Ryman, B. E., and Wiśniewski, H. M. 1977. Liposome toxicity in the mouse central nervous system. J. Neurological Sci. 31: 173-179.
2. Allen, T. M. 1994. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Advanced Drug Del. Rev. 13: 285-309.
3. Allen, T. M. 1997. Liposomes. Opportunities in drug delivery. Drugs, 54: 8-14.
4. Allen, T. M. and Cleland, L. G. 1980. Serum-induced leakage of liposome contents. Biochim. Biophys. Acta 597: 418-426.
5. Alving, C. R., Koulchin, V., Glenn, G. M., and Rao, M. 1995. Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunological. Rev. 145: 5-31.
6. Alving, C. R., Swartz, G. M., Jr., Wassef, N. M., Ribas, J. L., Herderick, E. E., Virmani, R., Kolodgie, F. D., Matyas, G. R., and Cornhill, J. F. 1996a. Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation. J. Lab. Clin. Med. 127: 40-49.
7. Alving, C. R., Wassef, N. M., and Potter, M. 1996b. Antibodies to cholesterol: biological implications of antibodies to lipids. Curr. Topics Microbiol. Immunol. 210: 181-186.
8. Aramaki, Y., Tomizawa, H., Hara, T., Yachi, K., Kikuchi, H., and Tsuchiya, S. 1993. Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral adminstration. Pharm. Res. 10: 1228-1231.
9. Ausborn, M., Nuhn, P., and Schreier, H. 1992. Stabilization of liposomes by freeze-thaw-and lyophilization techniques: problems and opportunities. Eur. J. Pharm. Biopharm. 38: 133-139.
10. Bangham, A. D. 1992. Liposomes: realiziing their promise. Hospital Practice 27: 51-62.
11. Bangham, A. D., Standish, M. M., and Watkins, J. C. 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13:238-252.
12. Betageri, G. V., Jenkins, S. A., and Parsons, D. L. 1993. Liposome Drug Delivery Systems. Technomic Publishing Co., Inc., Lancaster, PA.
13. Beveridge, T. J., Choquet, C. G., Patel, G. B., and Sprott, G. D. 1993. Freeze-fracture planes of methanogen membranes correlate with the content of tetraether lipids. J. Bacteriol. 175: 1191-1197.
14. Blöcher, D., Freisleben, J-H., and Ring, K. 1991. Thermotrophic properties of dispersions of cholesterol with tetraether lipids from Thermoplasma acidophilum. Arch. Biochem. Biophys. 290: 224-228.
15. Blöcher, D., Six, L., Gutermann, R., Henkel, B., and Ring, K. 1985. Physicochemical characterization of tetraether lipids from Thermoplasma acidophilum. Calorimetric studies on miscibility with diether model lipids carrying branched or unbranched alkyl chains. Biochim. Biophys. Acta 818: 333-342.
16. Bonté, F., Hsu, M. J., Papp, A., Wu, K., Regen, S. L., and Juliano, R. L. 1987. Interactions of polymerizable phosphatidylcholine vesicles with blood components: relevance to biocompatibility. Biochim. Biophys. Acta, 900: 1-9.
17. Boone, D. R., Whitman, W. B., and Rouvière, P. 1993. Diversity and taxonomy of methanogens. In: Methanogenesis. pp. 35-80. Ferry, J. G., Ed., Chapman & Hall, New York.
18. Brusa, T., Canzi, E., Allieve, L., Del Puppo, E., and Ferrari, A. 1993. Methanogens in the human intestinal tract and oral cavity. Curr. Microbiol. 27: 261-265.
19. Campbell, P. I. 1983. Toxicity of some charged lipids used in liposome preparations. Cytobios, 37:21-26.
20. Cavagnetto, F., Relini, A., Mirghani, Z., Gliozzi, A., Bertoia, D., and Gambacorta, A. 1992. Molecular packing parameters of bipolar lipids. Biochim. Biophys. Acta 1106: 273-281.
21. Chang, E. L. 1994. Unusual thermal stability of liposomes made from bipolar tetraether lipids. Biochem. Biophys. Res. Commun. 202: 673-679.
22. Chen, J. S., Barton, P. G., Brown, D., and Kates, M. 1974. Osmometric and microscopic studies on bilayers of polar lipids from the extreme halophile, Halobacterium cutirubrum. Biochim. Biophys. Acta 352: 202-217.
23. Chen, H., Torchilin, V., and Langer, R. 1996a. Polymerized liposomes as potential oral vaccine carriers: stability and bioavailability. J. Controlled Release, 42: 263-272.
24. Chen, H., Torchilin, V., and Langer, R. 1996b. Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm. Res. 13: 1378-1383.
25. Chiang, C-M. and Weiner, N. 1987a. Gastrointestinal uptake of liposomes. I. In vitro and in situ studies. Int. J. Pharm. 37: 75-85.
26. Chiang, C-M. and Weiner, N. 1987b. Gastrointestinal uptake of liposomes. II. In vivo studies. Int. J. Pharm. 37: 143-150.
27. Chonn, A. and Cullis, P. R. 1995. Recent advances in liposomal drug-delivery systems. Curr. Opin. Biotechnol. 6: 698-708.
28. Choquet, C. G., Patel, G. B., Beveridge, T. J., and Sprott, G. D. 1992. Formation of unilamellar liposomes from total polar lipid extracts of methanogens. Appl. Environ. Microbiol. 58: 2894-2900.
29. Choquet, C. G., Patel, G. B., Beveridge, T. J., and Sprott, G. D. 1994. Stability of pressure-extruded liposomes made from archaeobacterial ether lipids. Appl. Microbiol. Biotechnol. 42: 375-384.
30. Choquet, C. G., Patel, G. B., and Sprott, G. D. 1996. Heat sterilization of archaeal liposomes. Can. J. Microbiol. 42: 183-186.
31. Choquet, C. G., Patel, G. B., Sprott, G. D., and Beveridge, T. J. 1993. Stable liposomes formed from archaeal ether lipids. In: Advances in Bacterial Paracrystalline Surface Layers, pp. 257-268. Beveridge, T. J and Koval, S. F., Eds., Plenum Press, New York.
32. Couvreur, P. and Puisieux, F. 1993. Nano-and micro-particles for the delivery of polypeptides and proteins. Adv. Drug Del. Rev. 10: 141-162.
33. Cullis, P., Hope, M. J., de Kruyff, B., Verkleij, A. J., and Tilcock, T. P. S. 1985. Structural properties and functional roles of phospholipids in biological membranes. In: Phospholipids and cellular regulation. Vol. 1, pp. 1-58. Kuo, J. F., Ed., CRC Press, Boca Raton, Florida.
34. Dean, T. 1993. Liposomes in allergy and immunology. Clin. Exp. Allergy 23: 557-563.
35. Debrick, J. E., Campbell, P. A., and Staerz, U. D. 1991. Macrophages as accessory cells for class-I MHC-restricted immune responses. J. Immunol. 147: 2846-2851.
36. Derksen, J. T. P., Baldeschwieler, J. D., and Scherphof, G. L. 1988. In vivo stability of ester-and ether-linked phospholipid-containing liposomes as measured by perturbed angular correlation spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 85: 9768-9772.
37. De Rosa, M. and Gambacorta, A. 1988. The lipids of archaebacteria. Prog. Lipid Res. 27: 153-175.
38. De Rosa, M., Gambacorta, A., and Gliozzi, A. 1986. Structure, biosynthesis, and physicochemical properties of archaebacterial lipids. Microb. Rev. 50: 70-80.
39. Deshmukh, D. S., Bear, W. D., Wisniewski, H. M., and Brockerhoff, H. 1978. Long-living liposomes as potential drug carriers. Biochem. Biophys. Res. Comm. 82: 328-334.
40. Dijkstra, J., Swartz, G. M., Jr., Raney, J. J., Aniagolu, J., Toro, L., Nacy, C. A., and Green, S. J. 1996. Interaction of anti-cholesterol antibodies with human lipoproteins. J. Immunol. 157: 2006-2013.
41. Elferink, M. G. L., de Wit, J. G., Demel, R., Driessen, A. J. M., and Konings, W. N. 1992. Functional reconstitution of membrane proteins in monolayer liposomes from bipolar lipids of Sulfolobus acidocaldariiis. J. Biol. Chem. 267: 1375-1381.
42. Elferink, M. G. L., de Wit, J. G., Driessen, J. M., and Konings. 1994. Stability and proton-permeability of liposomes composed of archaeal tetraether lipids. Biochim. Biophys. Acta 1193: 247-254.
43. Elferink, M. G. L., van Breemen, J., Konings, W. N., Driessen, A. J. M., and Wilschut, J. 1997. Slow fusion of liposomes composed of membrane-spanning lipids. Chem. Phys. Lipids 88: 37-43.
44. Fan, C., Relini, A., Cassinadri, D., Gambacorta, A., and Gliozzi, A. 1995. Stability against temperature and external agents of vesicles composed of archaeal bolaform lipids and egg PC. Biochim. Biophys. Acta 1240: 83-88.
45. Ferrante, G., Ekiel, I., Patel, G. B., and Sprott, G. D. 1988. A novel core lipid isolated from the aceticlastic methanogen Methanothrix concilii GP6. Biochim. Biophys. Acta 963: 173-182.
46. Ferrante, G., Ekiel, I., and Sprott, G. D. 1987. Structure of diether lipids of Methanospirillum hungatei containing novel head groups N,N-dimethylamino-and N,N,N-trimethylaminopentanetetrol. Biochim. Biophys. Acta 921: 281-291.
47. Freisieben, H.-J., Bormann, J., Litzinger, D. C., Lehr, F., Rudolph, P., Schatten, W., and Huang, L. 1995. Toxicity and biodistribution of liposomes of the main phospholipid from the archaeobacterium Thermoplasma acidophilum in mice. J. Liposome Res. 5: 215-223.
48. Freisleben, H.-J., Neisser, C., Hartmann, M., Rudolph, P., Geek, P., Ring, K., and Müller, E. G. 1993. Influence of the main phospholipid (MPL) from Thermoplasma acidophilum and of liposomes from MPL on living cells: cytotoxicity and mutagenicity. J. Liposome Res. 3: 817-833.
49. Gliozzi, A., Mirghani, Z., and Relini, A. 1993. Bipolar lipid vesicles: a model for archaeobacterial membranes. J. Liposome Res. 3: 623-630.
50. Gregoriadis, G. (Ed). 1993. Liposome Technology. 2nd ed. Vol. 1-3. CRC Press, Boca Raton, Florida.
51. Gregoriadis, G. 1995. Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol. 13: 527-537.
52. Gregoriadis, G. 1998. Genetic vaccines: strategies for optimization. Pharm. Res. 15: 661-670.
53. Gregoriadis, G., Gursel, I., Gursel, M, and McCormack, B. 1996. Liposomes as immunological adjuvants and vaccine carriers. J. Controlled Rel. 41: 49-56.
54. Man, M., Watarai, S., Kobayashi, K., and Yasuda, T. 1997. Application of liposomes for development of oral vaccines: study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization. J. Vet. Med. Sci. 59: 1109-1114.
55. Hermetter, A. and Paltauf, F. 1983. Interaction between ether glycerophospholipid vesicles and serum proteins in vitro. Biochim. Biophys. Acta 752: 444-450.
56. Hoffman, A. F. 1963. The function of bile salts in fat absorption. The solvent properties of dilute micellar solutions of conjugated bile salts. Biochem. J. 89: 57-68.
57. Hope, M. J., Bally, M. B., Webb, G., and Cullis, P. R. 1985. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size, trapped volume and ability to maintain a membrane potential. Biochim. Biophys. Acta 813: 55-65.
58. Howard, B. 1998. A versatile encapsulation technology. Am. Biotechnol. 16: 22-24, 26.
59. Hřcková, G., Shah, A., Hart, D. T., and Halton, D. W. 1994. A comparative study of the utilization of ether-and ester-linked phospholipid-containing liposomes by J774.E1 macrophage cell-line infected with Leishmania mexicana mexicana amastigotes. Folia Parasitologica, 14: 161-167.
60. Iwanaga, K., Ono, S., Narioka, K., Morimoto, K., Kakemi, M., Yamashita, S., Nango, M., and Oku, N. 1997. Oral delivery of insulin by using surface coating liposomes. Improvement of stability of insulin in GI tract. Int. J. Pharm. 157: 73-80.
61. Kararli, T. T. 1995. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. 16: 351-380.
62. Kates, M. 1978. The phytanyl ether-linked polar lipids and isoprenoid neutral lipids of extremely halophilic bacteria. Progr. Chem. Fats Other Lipids 15:302-342.
63. Kates, M. 1993. Archaebacterial lipids: structure, biosynthesis and function. Biochem. Soc. Symp. 58: 51-72.
64. Kates, M. 1997. Diether and tetraether phospholipids and glycolipids as molecular markers for Archaebacteria (Archaea). Am. Chem. Soc. Symp. Series, 671: 35-47.
65. Kikuchi, H., Carlsson, A., Yachi, K., and Hirota, S. 1991. Possibility of heat sterilization of liposomes. Chem. Pharm. Bull. 39: 1018-1022.
66. Kirilenko, V. N. and Gregoriadis, G. 1993. Fat soluble vitamins in liposomes: studies on incorporation efficiency and bile salt induced vesicle disintegration. J. Drug Target. 1: 361-368.
67. 2 from human duodenal juice. Biochim. Biophys. Acta 1002: 395-397.
68. Krishnan, L., Dicaire, C. J., Patel, G. B., and Sprott, G. D. 1998. Archaeosomes as novel antigen delivery vehicles: upregulation of macrophages costimulatory activity. Abstracts of the 10th International Congress of Immunology, New Delhi, November 1-6, 1998.
69. Krishnan, L., Dicaire, C. J., Patel, G. B., and Sprott, G. D. 2000. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum. Infection and Immunity, In press.
70. Langer, R. 1998. Drug delivery targeting. Nature 392: 5-10.
71. Langworthy, T. A. 1985. Lipids of archaebacteria. In: The Bacteria. Vol VIII, pp. 459-497. Woese, C. R. and Wolfe, R. S., Eds., Academic Press, New York.
72. Lasic, D. D. 1998. Novel application of liposomes. Trends Biotechnol. 16: 307-321.
73. Lasic, D. D. and Templeton, N. S. 1996. Liposomes in gene therapy. Adv. Drug Del Rev. 20: 221-266.
74. Lelkes, P. I., Goldenberg, D., Gliozzi, A., De Rosa, M., Gambacorta, A., and Miller, I. R. 1983. Vesicles from mixtures of bipolar archaebacterial lipids with egg phosphatidylcholine. Biochim Biophys. Acta 732: 714-718.
75. Lichtenberg, D. and Barenholz, Y. 1988. Liposomes: preparation, characterization and preservation. Methods Biochem. Anal. 33: 337-462.
76. Lo, S-L. and Chang, E. L. 1990. Purification and characterization of a liposomal-forming tetraether lipid fraction. Biochem. Biophys. Res Commun. 167:238-243.
77. Maclean, A. L., Symonds, G., and Ward, R. 1997. Immuno-liposomes as targeted delivery vehicles for cancer therapeutics (review). Int. J. Oncol. 11: 325-332.
78. Madigan, M. T. and Marrs, B. L. 1997. Extremophiles. Sci. Am. 276: 82-87.
79. Makabi-Panzu, B., Lessard, C., Beauchamp, D., Désormeaux, A., Poulin, L., Tremblay, M., and Bergeron, M. G. 1995. Uptake and binding of liposomal 2′, 3′-dideoxycytidine by RAW 264.7 cells: a three-step process. J. Acq. Immune Defic. Synd. Human Retrovirol. 8: 227-235.
80. Makabi-Panzu, B., Sprott, G. D., and Patel, G. B. 1998. Coenzyme Q10 in vesicles composed of archaeal ether lipids or conventional lipids enhances the immuno-adjuvanticity to encapsulated protein. Vaccine 16: 1504-1510.
81. Mattai, J., Hauser, H., Demel, R. A., and Shipley, G. G. 1989. Interactions of metal ions with phosphatidylserine bilayer membranes: effect of hydrocarbon chain unsaturation. Biochemistry 28: 2322-2330.
82. Miller, T. L. and Wolin, M. J. 1986. Methanogens in human and animal intestinal tracts. System. Appl. Microbiol. 7: 223-229.
83. Mirghani, Z., Bertoia, D., Piano, E., and Gliozzi, A. 1989. Formation and properties of monopolar-bipolar mixed lipid vesicles. Biochem. Soc. Trans. 17: 507-508.
84. Moghimi, S. M. and Patel, H. M. 1989. Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. Biochim. Biophys. Acta 984: 384-387.
85. Morii, H., Nishihara, M., and Koga, Y. 1988. Composition of polar lipids of Methanobrevibacter arboriphilicus and structure determination of the signature phosphoglycolipid of Methanobacteriaceae. Agric. Biol. Chem. 52: 3149-3156.
86. Nagata, M., Yotsuyanagi, T., and Ikeda, K. 1988. A two-step model of disintegration kinetics of liposomes in bile salts. Chem. Pharm. Bull. 36: 1508-1513.
87. New, R. R. C. (Ed). 1990a. Liposomes: A Practical Approach. IRL Press at Oxford University Press, Oxford, UK.
88. New, R. R. C. 1990b. Preparation of liposomes. In: Liposomes: A Practical Approach, pp. 33-104. New, R. R. C., Ed., IRL Press at Oxford University Press, Oxford, UK.
89. O'Connor, C. J., Wallace, R. G., Iwamoto, K., Taguchi, T., and Sunamoto, J. 1985. Bile salt damage of egg phosphatidylcholine liposomes. Biochim. Biophys. Acta 817: 95-102.
90. O'Hagan, D. T. 1992. Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations. Clin. Pharmacokinet. 22: 1-10.
91. Okada, J., Cohen, S., and Langer, R. 1995. In vitro evaluation of polymerized liposomes as an oral drug delivery system. Pharm. Res. 12: 576-582.
92. Olsen, G. J. 1994. Archaea, Archaea, everywhere. Nature, 371: 657-658.
93. Omri, A., Makabi-Panzu, B., Agnew, B. J., Sprott, G. D., and Patel, G. B. 1999. Influence of coenzyme Q10 on tissue distribution of archaeosomes, and pegylated archaeosomes, administered to mice by oral and intravenous routes. J. Drug Target, (in press).
94. Pagano, R. E. and Weinstein, J. N. 1978. Interactions of liposomes with mammalian cells. Ann. Rev. Biophys. Bioeng. 7: 435-468.
95. Papahadjopoulos, D. 1978. Liposomes and their uses in biology and medicine. Ann. N. Y. Acad. Sci. 308: 367-368.
96. Papahadjopoulos, D. and Watkins, J. C. 1967. Phospholipid model membranes. II. Permeability properties of hydrated liquid crystals. Biochim. Biophys. Acta 135: 639-652.
97. Parnham, M. J. and Wetzig, H. 1993. Toxicity screening of liposomes. Chem. Phys. Lipids, 64: 263-274.
98. Patel, G. B., Agnew, B. J., Deschatelets, L., Fleming, L. P., and Sprott, G. D. 1999a. In vitro assessment of archaeosome stability for developing oral delivery systems. Int. J. Pharm. 194: 39-49.
99. Patel, G. B., Agnew, B. J., and Dicaire, C. J. 1991. Inhibition of pure cultures of methanogens by benzene ring compounds. Appl. Environ. Microbiol. 57: 2969-2974.
100. Patel, G. B., Agnew, B. J., Jarrell, H. C., and Sprott, G. D. 1999b. Stability of liposomes prepared from the total polar lipids of Methanosarcina mazei is affected by the specific salt form of the lipids. J. Liposome Res. 9: 229-245.
101. Patel, G. B., Baudet, C., and Agnew, B. J. 1988. Nutritional requirements for growth of Methanothrix concilii. Can. J. Microbiol. 34: 73-77.
102. 13C]acetate. Appl. Environ. Microbiol. 59: 1099-1103.
103. Patel, H. M. 1992. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit. Rev. Therap. Drug Carrier Syst. 9: 39-90.
104. Quaite-Randall, E., Trent, J. D., Josephs, R., and Joachimiak, A. 1995. Conformational cycle of the archaeosome, a TCP1 -like chaperonin from Sulfolobus shibatae. J. Biol. Chem. 270: 28818-28823.
105. Quinn, P. J., Brain, A. P. R., Stewart, L. C., and Kates, M. 1986. The structure of membrane lipids of the extreme halophile, Halobacterium cutirubrum, in aqueous systems studied by freeze-fracture. Biochim. Biophys. Acta 863: 213-223.
106. Ranson, M., Howell, A., Cheeseman, S., and Margison, J. 1996. Liposomal drug delivery. Cancer Treat. Rev. 22: 365-379.
107. Relini, A., Cassinadri, D., Mirghani, Z., Brandt, O., Gambacorta, A., Trincone, A., De Rosa, M., and Gliozzi, A. 1994. Calcium-induced interaction and fusion of archaeobacterial lipid vesicles: a fluorescence study. Biochim. Biophys. Acta 1194: 17-24.
108. Richards, M. H. and Gardner, C. R. 1978. Effects of bile salts on the structural integrity of liposomes. Biochim. Biophys. Acta 543: 508-522.
109. Ring, K., Henkel, B., Valenteijn, A., and Gutermann, R. 1986. Studies on the permeability and stability of liposomes derived from a membrane-spanning bipolar archaebacterial tetraetherlipid. In: Liposomes As Drug Carriers. pp. 101-123. Schmidt, K. H., Ed., Thieme, Stuttgart.
110. Robb, F. T., Place, A. R., Sowers, K, R., Schreier, H. J., DasSarma, S., and Fleischmann, E. M., Eds. 1995. Archaea: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Plainview, New York.
111. Rogers, J. A. and Anderson, K. E. 1998. The potential of liposomes in oral drug delivery. Crit. Rev. Therap. Drug Carrier Syst. 15: 421-480.
112. Rongen, H. A. H., Bult, A., and van Bennekom, W. P. 1997. Liposomes and immunoassays. J. Immunol. Methods 204: 105-133.
113. Rowland, R. N. and Woodley, J. F. 1980. The stability of liposomes in vitro to pH, bile salts and pancreatic lipase. Biochim. Biophys. Acta 620: 400-409.
114. Scherphof, G. L. 1991. In vivo behavior of liposomes: interactions with mononuclear phagocyte system and implications for drug targeting. In: Targeted Drug Delivery, pp. 285-327. Juliano, R. L., Ed., Springer-Verlag, New York.
115. Scherphof, G. L., Damen, J., and Wilschut, J. 1984. Interactions of liposomes with plasma proteins. In: Liposome Technology. Vol. 3, pp. 205-224. Gregoriadis, G., Ed., CRC Press, Boca Raton, Florida.
116. Semple, S. C., Chonn, A., and Cullis. P. R. 1996. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry 35: 2521-2525.
117. Senior, J. H. 1987. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3: 123-193.
118. Sharma, A. and Sharma, U. 1997. Liposomes in drug delivery: progress and limitations. Int. J. Pharmaceut. 154: 123-140.
119. Shek, P. N., Yung, B. Y. K., Stanacev, N. Z. 1986. Physicochemical and immunological properties of albumin-associated dialkyl-ether phosphatidylcholine liposomes. Biochim. Biophys. Acta 855: 33-40.
120. Siler-Marinkovic, S., Mojovic, L., Davinic, V., and Bugarski, B. 1997. Liposomes as carriers of antimicrobial drugs. Drug Dev. Industr. Pharm. 23: 483-488.
121. Snyder, F. 1991. Metabolism, regulation, and function of ether-linked glycerolipids and their bioactive species. In: Biochemistry of Lipids, Lipoproteins and Membranes. pp. 241-267. Vance, D. E. and Vance, J., Eds., Elsevier Science Publishers B. V., Amsterdam.
122. Sprott, G. D. 1992. Structures of archaebacterial membrane lipids. J. Bioenrg. Biomembr. 24: 555-566.
123. Sprott, G. D., Agnew, B. J., and Patel, G. B. 1997a. Structural features of ether lipids in the archaeobacterial thermophiles Pyrococcus furiosus, Methanopyrus kandleri, Methanothermus fervidus, and Sulfolobus acidocaldarius. Can. J. Microbiol. 43: 467-476.
124. Sprott, G. D., Brisson, J-R., Dicaire, C. J., Pelletier, A. K., Deschatelets, L., Krishnan, L., and Patel, G. B. 1999. A structural comparison of the total polar lipids from the human archaea Methanobrevibacter smithii and Methanosphaera stadtmanae and its relevance to the adjuvant activities of their liposomes. Biochim. Biophys. Acta 1440: 275-288.
125. Sprott, G. D., Choquet, C. G., and Patel, G. B. 1995. Purification of ether lipids and liposome formation from polar lipid extracts of methanogenic Archaea. In: Methanogens. Archaea - A Laboratory Manual, Sowers, K. R., et al. (Eds.), pp. 329-340. Cold Spring Harbor Laboratory Press, Plainview, NY.
126. Sprott, G. D., Dicaire, C. J., Choquet, C. G., Patel, G. B., and Ekiel, I. 1993a. Hydroxydiether lipid structures in Methanosarcina spp. and Methanococcus voltae. Appl. Environ. Microbiol. 59: 912-914.
127. Sprott, G. D., Dicaire, C. J., Fleming, L. P., and Patel, G. B. 1996. Stability of liposomes prepared from archaeobacterial lipids and phosphatidylcholine mixtures. Cells Mater., 6: 143-155.
128. Sprott, G. D., Dicaire, C. J., and Patel, G. B. 1994. The ether lipids of Methanosarcina mazei and other Methanosarcina species, compared by fast atom bombardment mass spectrometry. Can. J. Microbiol. 40: 837-843.
129. Sprott, G. D., Ekiel, I., and Dicaire, C. 1990. Novel, acid-labile, hydroxydiether lipid cores in methanogenic bacteria. J. Biol. Chem. 265: 13735-13740.
130. Sprott, G. D., Ekiel, I., and Patel, G. B. 1993b. Metabolic pathways in Methanococcus jannaschii and other methanogenic bacteria. Appl. Environ. Microbiol. 59: 1092-1098.
131. Sprott, G. D., Meloche, M., and Richards, J. C. 1991. Proportions of diether, macrocyclic diether, and tetraether lipids in Methanococccus jannaschii grown at different temperatures. J. Bacteriol. 173: 3907-3910.
132. Sprott, G. D., Patel, G. B., Choquet, C. G., and Ekiel, I. 1993c. Formation of stable liposomes from lipid extracts of archaeobacteria (Archaea). PCT International Publication No. WO 93/08202, published April 29,1993. European Patent No. 0610289; United States Patent No. 5989587 pending in Canada and Japan.
133. 10 as adjuvants and as delivery vehicles. Priority date of December 15, 1995. PCT International Publication No. WO 97/ 22333.
134. Sprott, G. D., Tolson, D. L., and Patel, G. B. 1997c. Archaeosomes as novel antigen delivery systems. FEMS Microbiol. Lett. 154: 17-22.
135. Stein, Y., Halperin, G., Leitersdorf, E., Dabach, Y., Hollander, G., and Stein, O. 1984. Metabolism of liposomes prepared from a labeled ether analog of 1,2-dioleoyl-sn-glycero-3-phosphocholine in the rat. Biochim. Biophys. Acta 793: 354-364.
136. Stern, J., Freisleben, H-J., Janku, S., and Ring, K. 1992. Black lipid membranes of tetraether lipids from Thermoplasma acidophilum. Biochim. Biophys. Acta 1128: 227-236.
137. 31P-NMR study. Chem. Phys. Lipids 54: 115-129.
138. Swain, M., Brisson, J-R., Sprott, G. D., Cooper, F. P., and Patel, G. B. 1997. Identification of β-L-gulose as the sugar moiety of the main polar lipid of Thermoplasma acidophilum. Biochim. Biophys. Acta 1345: 56-64.
139. Szoka, F., Jr. and Papahadjopoulos, D. 1980. Comparative properties and methods of preparation of lipid vesicles (liposomes). Ann. Rev. Biophys. Bioeng. 9: 467-508.
140. Tilcock, C. P. S., Cullis, P. R., and Gruner, S. M. 1988. Calcium-induced phase separation phenomena in multicomponent unsaturated lipid mixtures. Biochemistry 27: 1415-1420.
141. Tolson, D. L., Latta, R. K., Patel, G. B., and Sprott, G. D. 1996. Uptake of archaeobacterial liposomes and conventional liposomes by phagocytic cells. J. Liposome Res. 64: 755-776.
142. Torchilin, V. P. 1996. Liposomes as delivery agents for medical imaging. Mol. Med. Today 2: 242-249.
143. van Rooijen, N. 1994. Liposomes in host defense mechanism: a key role for macrophages. J. Liposome Res. 4: 193-201.
144. Wang, W. 1996. Oral protein drug delivery. J. Drug Target. 4: 195-232.
145. Wasan, K. M. and Lopez-Berestein, G. 1995. The past, present, and future uses of liposomes in treating infectious diseases. Immunopharmacol. Immunotoxicol. 17: 1-15.
146. Watwe, R. M. and Bellare, J. R. 1995. Manufacture of liposomes: a review. Curr. Sci. 68: 715-724.
147. Webb, M. S., Harasym, T. O., Masin, D., Bally, M. B., and Mayer, L. D. 1995. Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumor models. Br. J. Cancer 72: 896-904.
148. Weiner, A. L., Cannon, J. B., and Tyle, P. 1989. Commercial approaches to the delivery of macromolecular drugs with liposomes. In: Controlled Release of Drugs: Polymers and Aggregate Systems, pp. 217-252. Rosoff, M., Ed., VCH Publishers, New York.
149. Woodle, M. C. and Lasic, D. D. 1992. Sterically stabilized liposomes. Biochim. Biophys. Acta 1113: 171-199.
150. Woodley, J. F. 1984. Liposomes for oral administration of drugs. CRC Crit. Rev. Ther. Drug Carrier Syst. 2: 2-18.
151. Yamauchi, K., Doi, K., Kinoshita, M., Kii, F., and Fukuda, H. 1992. Archaebacterial lipid models: highly salt-tolerant membranes from 1,2-diphytanylglycero-3-phosphocholine. Biochim. Biophys. Acta 1110: 171-177.
152. Zuidam, N. J., Lee, S. S. L., and Crommelin, D. J. A. 1993. Sterilization of liposomes by heat. Pharm. Res. 10: 1591-1596.